Converge VC

Converge VC is an early-stage venture firm with a website and LinkedIn presence but limited public detail in the source data on healthcare specialization, stage discipline, or check sizing. The name is shared by multiple unrelated venture firms globally, including a Boston-area enterprise software fund and others, which makes generic positioning claims unreliable without firm-specific verification. For healthcare AI founders, the practical implication is that Converge should be treated as a generalist seed or Series A investor unless and until the founder confirms current healthcare exposure through the firm’s portfolio page or a direct conversation. If the firm’s thesis is enterprise SaaS or applied AI broadly, healthcare workflow automation, clinical decision support tooling, and revenue cycle AI startups could plausibly fit, but biotech, devices, and diagnostics almost certainly do not. Check sizes for a firm at this profile typically range from $500K to $3M as a lead or co-lead at seed, with reserves for follow-on. The right entry path is a warm intro from a portfolio company founder or a known co-investor, since cold inbound to a generalist fund without a specific healthcare hook rarely converts. Founders should pre-qualify the fit by reading the most recent six to twelve months of portfolio additions and partner content before any meeting, and should be prepared to articulate why a non-specialist firm is the right fit for their stage rather than a healthcare-dedicated fund. With this little public signal, treat Converge as a possible co-investor rather than a lead and prioritize accordingly.